TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 3.610
AS - Asia 2.343
EU - Europa 1.851
SA - Sud America 466
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 71
OC - Oceania 4
Totale 8.501
Nazione #
US - Stati Uniti d'America 3.389
SG - Singapore 913
IT - Italia 583
CN - Cina 474
BR - Brasile 348
HK - Hong Kong 297
DE - Germania 277
RU - Federazione Russa 272
VN - Vietnam 256
IE - Irlanda 197
CA - Canada 164
SE - Svezia 128
BD - Bangladesh 80
GB - Regno Unito 75
FR - Francia 65
IN - India 57
FI - Finlandia 48
AT - Austria 42
AR - Argentina 39
KR - Corea 35
TR - Turchia 35
ZA - Sudafrica 30
ES - Italia 29
MX - Messico 29
NL - Olanda 29
PK - Pakistan 29
UA - Ucraina 29
JP - Giappone 26
ID - Indonesia 25
PL - Polonia 22
EC - Ecuador 21
IQ - Iraq 21
PH - Filippine 16
CL - Cile 14
CO - Colombia 14
EG - Egitto 14
VE - Venezuela 14
DK - Danimarca 13
SA - Arabia Saudita 11
MA - Marocco 8
MY - Malesia 8
IL - Israele 7
JM - Giamaica 7
UZ - Uzbekistan 7
IR - Iran 6
JO - Giordania 6
LT - Lituania 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
UY - Uruguay 5
AU - Australia 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
KZ - Kazakistan 4
PA - Panama 4
RO - Romania 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
DZ - Algeria 3
HN - Honduras 3
LB - Libano 3
NI - Nicaragua 3
PE - Perù 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
LY - Libia 2
NP - Nepal 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 8.339
Città #
Singapore 580
Ann Arbor 509
Ashburn 344
Hong Kong 288
San Jose 281
Chandler 196
Frankfurt am Main 195
Dublin 192
Woodbridge 168
Milan 146
Fairfield 129
Toronto 114
New York 104
Beijing 93
Wilmington 91
Dallas 89
Los Angeles 83
Ho Chi Minh City 81
The Dalles 67
Hanoi 64
Santa Clara 64
Hefei 58
Houston 57
Chicago 56
Seattle 53
Princeton 51
Shanghai 49
Rome 43
Cambridge 41
Jacksonville 40
São Paulo 38
Lissone 34
Moscow 34
Munich 33
Seoul 33
Boardman 32
Dearborn 30
Vienna 30
Lauterbourg 29
Buffalo 28
Altamura 24
Lawrence 23
Brooklyn 20
Tokyo 20
London 18
Jakarta 17
Nanjing 17
Turku 17
Warsaw 17
Montreal 16
Council Bluffs 15
Helsinki 15
Johannesburg 14
Orem 14
Nuremberg 13
Ottawa 12
Chennai 11
Da Nang 11
Lachine 11
Columbus 10
Denver 10
Phoenix 10
Rio de Janeiro 10
San Diego 10
Andover 9
Caronno Pertusella 9
Istanbul 9
Lahore 9
Mexico City 9
Alexandria 8
Bologna 8
Boston 8
Brasília 8
Charlotte 8
Guangzhou 8
Hangzhou 8
San Francisco 8
Turin 8
Washington 8
Xi'an 8
Baghdad 7
Belo Horizonte 7
Buenos Aires 7
Campinas 7
Changsha 7
Curitiba 7
Figino 7
Florence 7
Pavia 7
Quito 7
Shenyang 7
Stockholm 7
Tashkent 7
Atlanta 6
Cape Town 6
Caracas 6
Coventry 6
Jinan 6
Karachi 6
Manchester 6
Totale 5.268
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 389
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 357
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 331
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 314
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 306
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 305
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 293
Novel Therapies in Takayasu Arteritis 286
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 285
Neutrophil Extracellular Traps in the Autoimmunity Context 282
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 275
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 268
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 259
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 256
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 249
Immunology of membranous nephropathy: From animal models to humans 238
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 237
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 233
Evidence for charge-based mimicry in anti dsDNA antibody generation 231
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 222
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 221
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 216
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 216
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 209
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 206
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 200
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 194
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 193
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 191
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 188
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 179
ANCA-associated vasculitides (AAV) from the gender point of view 178
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 174
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 166
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 154
Totale 8.501
Categoria #
all - tutte 27.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.621


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022340 0 67 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/20251.617 59 120 127 73 113 59 141 50 184 300 169 222
2025/20263.724 442 208 305 406 455 208 526 158 238 279 182 317
2026/2027154 135 19 0 0 0 0 0 0 0 0 0 0
Totale 8.501